Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has completed its ...

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

Regeneron Pharmaceuticals, which has a plant in Rensselaer County, is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11. Biotechnology company ...

May 9 (UPI) --A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which is scheduled to retire animal testing. Organoid Science ...

The company said in a release last month about a human clinical trial that it is “a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating ...